Comorbidity prevalence, healthcare utilization, and expenditures of Medicaid enrolled adults with autism spectrum disorders
- PMID: 27875247
- PMCID: PMC5517354
- DOI: 10.1177/1362361316665222
Comorbidity prevalence, healthcare utilization, and expenditures of Medicaid enrolled adults with autism spectrum disorders
Abstract
A retrospective data analysis using 2000-2008 three state Medicaid Analytic eXtract was conducted to examine the prevalence and association of comorbidities (psychiatric and non-psychiatric) with healthcare utilization and expenditures of fee-for-service enrolled adults (22-64 years) with and without autism spectrum disorders (International Classification of Diseases, Ninth Revision-clinical modification code: 299.xx). Autism spectrum disorder cases were 1:3 matched to no autism spectrum disorder controls by age, gender, and race using propensity scores. Study outcomes were all-cause healthcare utilization (outpatient office visits, inpatient hospitalizations, emergency room, and prescription drug use) and associated healthcare expenditures. Bivariate analyses (chi-square tests and t-tests), multinomial logistic regressions (healthcare utilization), and generalized linear models with gamma distribution (expenditures) were used. Adults with autism spectrum disorders (n = 1772) had significantly higher rates of psychiatric comorbidity (81%), epilepsy (22%), infections (22%), skin disorders (21%), and hearing impairments (18%). Adults with autism spectrum disorders had higher mean annual outpatient office visits (32ASD vs 8noASD) and prescription drug use claims (51ASD vs 24noASD) as well as higher mean annual outpatient office visits (US$4375ASD vs US$824noASD), emergency room (US$15,929ASD vs US$2598noASD), prescription drug use (US$6067ASD vs US$3144noASD), and total expenditures (US$13,700ASD vs US$8560noASD). The presence of a psychiatric and a non-psychiatric comorbidity among adults with autism spectrum disorders increased the annual total expenditures by US$4952 and US$5084, respectively.
Keywords: Medicaid; autism spectrum disorders; economic costs; healthcare expenditures; healthcare utilization; medical comorbidity; psychiatric comorbidity.
References
-
- Ahmedani BK, Hock RM. Health care access and treatment for children with co-morbid autism and psychiatric conditions. Social Psychiatry and Psychiatric Epidemiology. 2012;47(11):1807–1814. - PubMed
-
- Arjun L, Hope C, Guyer J, et al. Medicaid and its role for children and youth with special health care needs (CYSHCN): A family perspective. Georgetown University, Health Policy Institute: Center for Children and Families. Albuquerque, NM: Family Voices; 2011.
-
- Autism Speaks. [accessed 2 March 2016];High-quality early intervention for autism more than pays for itself. 2013 Available at: http://www.autism-speaks.org/science/science-news/high-quality-early-int....
-
- Bailey DB, Jr, Hebbeler K, Scarborough A, et al. First experiences with early intervention: a national perspective. Pediatrics. 2004;113(4):887–896. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
